Preventing the Progression of Episodic Migraine to Chronic Migraine with Acute Treatment Optimization
- PMID: 35137337
- DOI: 10.1007/s11916-022-01022-0
Preventing the Progression of Episodic Migraine to Chronic Migraine with Acute Treatment Optimization
Abstract
Purpose of review: To evaluate the evidence regarding acute migraine treatment optimization to prevent the progression of episodic migraine to chronic migraine. This review also provides a summary of evidence-based acute migraine treatments and how to tailor a regimen based on an individual patient's needs.
Recent findings: Several acute migraine treatments have been food and drug administration (FDA)-approved since 2020. This review summarizes pain freedom data at 2 h for these medications and devices and examines the classic acute migraine treatments. This review presents the existing data about acute treatment optimization and its preventive role in the progression of episodic migraine to chronic migraine. We present updated clinical trial efficacy endpoints from the American Headache Society (AHS) and the FDA and review the evidence for acute migraine treatments currently available in clinical practice.
Keywords: Acute treatment; Headache; Migraine.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
References
Papers of particular interest, published recently, have been highlighted as:
• Of importance
-
- • Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38:1–211. This reference is a resource which provides specific criteria which are needed for the diagnosis of various headache disorders.
-
- Lipton RB, et al. The effect of psychiatric comorbidities on headache-related disability in migraine: results from the chronic migraine epidemiology and outcomes (CaMEO) study. Headache. 2020;60:1683–96. - DOI
-
- Sanderson JC, et al. Headache-related health resource utilisation in chronic and episodic migraine across six countries. J Neurol Neurosurg Psychiatry. 2013;84:1309–17. - DOI
-
- Dodick DW, et al. Assessing barriers to chronic migraine consultation, diagnosis, and treatment: results from the chronic migraine epidemiology and outcomes (CaMEO) study. Headache. 2016;56:821–34. - DOI
-
- Ailani J, Burch RC, Robbins MS. The American Headache Society Consensus Statement: update on integrating new migraine treatments into clinical practice. Headache. 2021;61(7):1021–39. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
